D

Dishman Pharmaceuticals and Chemicals Ltd(Merged)

DISHMAN NSE
This stock has been delisted or merged and is no longer actively traded.

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

3
  • Stock is trading at 2.90 times its book value
  • The company has delivered a poor sales growth of 9.13% over past five years.
  • Company has a low return on equity of 10.9% over last 3 years.

Growth Rate

Revenue Growth
7% lower than 3Y
Net Income Growth
6% lower than 3Y

Quarterly Results

Particulars Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017
Sales
409
363
403
390
424
404
380
392
422
375
437
362
534
Expenses
322
287
316
316
348
298
286
280
318
273
321
267
388
Operating Profit
88
75
88
74
76
106
94
112
105
102
116
95
146
OPM %
21%
21%
22%
19%
18%
26%
25%
29%
25%
27%
27%
26%
27%
Other Income
17
4
1
8
73
4
8
-1
13
7
8
16
4
Interest
25
21
18
26
25
32
26
18
20
22
19
13
10
Depreciation
29
31
24
25
71
26
34
31
30
28
31
51
57
PBT
50
29
47
31
53
52
42
62
67
58
74
46
83
Tax %
55%
17%
29%
21%
27%
23%
34%
27%
26%
22%
26%
37%
48%
Net Profit
23
24
33
24
39
40
28
44
50
46
55
29
43
EPS in Rs
2.8
2.95
4.13
2.98
4.78
4.96
3.44
5.55
6.19
2.82
3.39
1.79
2.65
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016TTM
Sales
277
578
803
1,062
915
1,031
1,124
1,272
1,385
1,589
1,596
1,708
Expenses
213
468
659
801
712
830
899
982
1,053
1,275
1,186
1,249
Operating Profit
65
110
144
261
203
202
225
290
332
314
410
460
OPM %
23%
19%
18%
25%
22%
20%
20%
23%
24%
20%
26%
27%
Other Income
12
31
60
8
29
14
13
18
25
86
27
34
Interest
10
19
34
49
39
56
73
79
92
90
94
65
Depreciation
12
26
47
63
59
69
77
84
109
151
109
168
PBT
55
96
123
157
134
91
88
145
156
159
233
261
Tax %
6%
4%
2%
7%
13%
12%
35%
31%
30%
25%
27%
—
Net Profit
51
92
120
146
117
80
57
100
109
120
171
172
EPS in Rs
—
12.7
15.02
18.12
14.55
9.91
7.03
12.43
13.54
14.85
21.2
10.65
Div. Payout %
9%
8%
7%
7%
8%
12%
17%
10%
9%
13%
9%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Equity Capital
14
14
16
16
16
16
16
16
16
16
16
Reserves
175
301
558
688
768
863
915
1,018
1,165
1,222
1,435
Borrowings
325
561
630
724
774
868
850
854
974
933
943
Other Liabilities
82
285
262
224
232
334
469
403
472
638
586
Total Liabilities
596
1,161
1,466
1,652
1,790
2,081
2,249
2,291
2,628
2,809
2,981
Fixed Assets
175
538
685
778
843
1,012
1,033
1,373
1,505
1,441
1,545
CWIP
37
65
148
223
357
307
418
97
79
142
85
Investments
7
14
1
1
1
1
26
25
25
25
25
Other Assets
376
544
631
650
588
761
771
796
1,019
1,201
1,325
Total Assets
596
1,161
1,466
1,652
1,790
2,081
2,249
2,291
2,628
2,809
2,981
Figures in ₹ Crores

Cash Flow

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Operating
15
43
49
132
302
203
154
165
344
294
279
Investing
-82
-418
-252
-168
-295
-231
-104
-117
-257
-158
-153
Financing
192
275
205
44
-7
25
-68
-50
-74
-142
-94
Net Cash Flow
126
-100
2
8
0
-3
-18
-2
14
-6
32
Free Cash Flow
-68
-373
-220
-37
-2
-37
59
31
56
156
158
CFO/OP
29
44
41
56
157
107
74
63
113
108
82
Figures in ₹ Crores

Ratios

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Debtor Days
114
79
80
51
45
60
61
21
38
50
35
Inventory Days
306
537
375
339
316
272
253
328
414
298
524
Days Payable
134
118
74
55
104
172
157
102
82
101
94
Cash Conversion Cycle
286
498
381
335
258
160
157
247
369
247
465
Working Capital Days
208
151
157
138
137
98
92
103
118
109
140
ROCE %
—
16%
14%
16%
12%
9%
9%
12%
12%
12%
14%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Dishman Pharmaceuticals and Chemicals Ltd(Merged) insights

62 extracted metrics + investor summaries across FY06–FY18.

Log in — free

Shareholding Pattern

DIIs9.92%Promot.61.40%FIIs10.92%Public17.76%As ofMar 2017

Documents

Frequently Asked Questions about Dishman Pharmaceuticals and Chemicals Ltd(Merged)

What does Dishman Pharmaceuticals and Chemicals Ltd(Merged) do?
Dishman Pharmaceuticals and Chemicals Limited operates as an outsourcing partner for the pharmaceutical industry. The Company manufactures and supplies intermediates, fine chemicals and various products for pharmaceutical, cosmetic and related industries.
Where is Dishman Pharmaceuticals and Chemicals Ltd(Merged) (DISHMAN) listed?
Dishman Pharmaceuticals and Chemicals Ltd(Merged) trades as DISHMAN on the NSE.
Which sector does Dishman Pharmaceuticals and Chemicals Ltd(Merged) belong to?
Dishman Pharmaceuticals and Chemicals Ltd(Merged) is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Dishman Pharmaceuticals and Chemicals Limited operates as an outsourcing partner for the pharmaceutical industry. The Company manufactures and supplies intermediates, fine chemicals and various products for pharmaceutical, cosmetic and related industries.

Website dishmangroup.com
Face Value ₹ 2

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/DISHMAN.md for Dishman Pharmaceuticals and Chemicals Ltd(Merged): company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List